Public-Private Partnerships for Neuropsychiatric Drug Development: A Perspective
{{output}}
There is a long-standing interest in developing biomarkers for neuropsychiatric disorders that might assist in drug development or clinical management. To date, however, progress has been limited in part because of the limited nature of the studies and the abs... ...
